N
NeuroPace, Inc.
NPCE · NASDAQ · Healthcare · 504M
Closing price
$12.67
+2.26% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
21.8×
Enterprise value / EBITDAEV/EBITDA
-38.5×
Free cash flow yieldFCF yield
-2.7%
Return on equityROE
-112.8%
Operating margin
-16.3%
Net debt / EBITDAbalance-sheet strength
-4.1×
Interest coverage
-2.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.